Effects of Cytokines and Other Agents on Clonogenic Growth of KS-1 and BC-1 Cell Lines
| Cytokines and Other Agents . | Effect on Clonal Growth of PEL Cell Lines . | |
|---|---|---|
| KS-1 . | BC-1 . | |
| Human IL-6 antisense | Inhibition | Inhibition |
| (10 μmol/L) | (95%)* | (98%)* |
| Viral IL-6 antisense | NE | NE |
| (1 to 10 μmol/L) | ||
| Human IL-10† | NE | NE |
| Human IL-10 antisense | NE | NE |
| IFN-α | Inhibition | NE |
| (1,000 U/mL) | (99%)* | |
| IFN-γ | Inhibition | NE |
| (1,000 U/mL) | (48%)* | |
| IL-6† | NE | NE |
| GM-CSF† | NE | NT |
| Oncostatin M† | NE | NT |
| IL-4† | NE | NE |
| IL-8† | NE | NE |
| ATRA† | NE | NT |
| hCG α and β† | NE | NT |
| Cytokines and Other Agents . | Effect on Clonal Growth of PEL Cell Lines . | |
|---|---|---|
| KS-1 . | BC-1 . | |
| Human IL-6 antisense | Inhibition | Inhibition |
| (10 μmol/L) | (95%)* | (98%)* |
| Viral IL-6 antisense | NE | NE |
| (1 to 10 μmol/L) | ||
| Human IL-10† | NE | NE |
| Human IL-10 antisense | NE | NE |
| IFN-α | Inhibition | NE |
| (1,000 U/mL) | (99%)* | |
| IFN-γ | Inhibition | NE |
| (1,000 U/mL) | (48%)* | |
| IL-6† | NE | NE |
| GM-CSF† | NE | NT |
| Oncostatin M† | NE | NT |
| IL-4† | NE | NE |
| IL-8† | NE | NE |
| ATRA† | NE | NT |
| hCG α and β† | NE | NT |